 Advertisement | ||||||||
 | ||||||||
|
||||||||
 |
 |
 |
 |
 |
 |
 |
||
Canadian Medical Association Journal, Vol 131, Issue 1 25-32, Copyright © 1984 by Canadian Medical Association
JOURNAL ARTICLE |
C. H. Jackson, N. C. MacDonald and J. W. Cornett
Acetaminophen is an effective analgesic and antipyretic agent with few adverse effects when used in recommended dosages. The drug is metabolized mainly in the liver, and the several end products have no harmful effects. An intermediate compound in a minor metabolic pathway, however, is toxic; it is normally inactivated by glutathione. In the case of an acetaminophen overdose the hepatic stores of glutathione seem to become depleted, leaving the toxic intermediate free to damage liver tissue. Such damage is unlikely to occur unless the plasma concentration of acetaminophen peaks above 150 micrograms/mL--a level far in excess of the 5 to 20 micrograms/mL achieved with therapeutic doses of the drug. Long-term therapeutic use of acetaminophen does not appear to be associated with liver damage, although some case reports suggest the possibility. Acetaminophen poisoning follows an acute overdose and, if untreated, is manifested clinically by an initial phase of nonspecific signs and symptoms, a latent period in which the liver transaminase levels rise and then, 3 to 5 days after the ingestion, signs of more serious hepatic dysfunction. Most patients do not progress beyond the first or second phase. They and those who survive the third phase recover with no residual injury to the liver. Appropriate antidotal therapy markedly reduces the severity of the initial damage.
This article has been cited by other articles:
|
|
 |
|
  F. Khwaja, J. Allen, J. Lynch, P. Andrews, and D. Djakiew Ibuprofen Inhibits Survival of Bladder Cancer Cells by Induced Expression of the p75NTR Tumor Suppressor Protein Cancer Res., September 1, 2004; 64(17): 6207 - 6213. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Rawal, R. Allvin, A. Amilon, T. Ohlsson, and J. Hallen Postoperative Analgesia at Home After Ambulatory Hand Surgery: A Controlled Comparison of Tramadol, Metamizol, and Paracetamol Anesth. Analg., February 1, 2001; 92(2): 347 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Shah, A. Taddio, and A. Ohlsson Randomised controlled trial of paracetamol for heel prick pain in neonates Arch. Dis. Child. Fetal Neonatal Ed., November 1, 1998; 79(3): 209F - 211. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. J M de Craen, G. Di Giulio, A. J E M Lampe-Schoenmaeckers, A. G H Kessels, and J. Kleijnen Analgesic efficacy and safety of paracetamol-codeine combinations versus paracetamol alone: a systematic review BMJ, August 10, 1996; 313(7053): 321 - 325. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. R. Griffin, K. D. Brandt, M. H. Liang, T. Pincus, and W. A. Ray Practical Management of Osteoarthritis: Integration of Pharmacologic and Nonpharmacologic Measures Arch Fam Med, December 1, 1995; 4(12): 1049 - 1055. [Abstract] [PDF]
|
|
|
|
 |
|
 B. Styrt and B. Sugarman Antipyresis and Fever Arch Intern Med, August 1, 1990; 150(8): 1589 - 1597. [Abstract] [PDF]
|
|
| HOME | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | HELP | SEARCH |
|
|||||
|
Copyright 1995-1984, Canadian Medical Association. All rights reserved. ISSN 1488-2329
(e) 0820-3946 (p)
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association. |
|||||
